**4. Conclusion**

The available literature suggests that vitamin E bonding on the cellulosic membrane Excebrane can reduce oxidative stress, as assessed by the levels of lipid peroxidation markers, and improve laboratory indices of inflammation and uremic anemia. The newly developed synthetic polysulfone-based dialysis membrane VitabranE appears to produce even more relevant clinical advantages as it is a homologue of most widely used synthetic membrane dialyzers. Randomized studies carried out in the past few years, which have

Review of the Effectiveness of Cellulose-

*Contrib Nephrol.* 137:371–8.

*Dial Transplant.* 22 Suppl 5:v20–36.

red blood cells. *Kidney Int*. 63(5):1881–7.

*Nephrol Dial Transplant*. 20(9):1932–5.

dialysis patients. *Kidney Int.* 65(4):1473–81.

dialyzer. *Int J Artif Organs.* 33(3):147–153.

coated dialyzer. *Circulation*. 101(9):1002–6.

pilot study. *Int J Nephrol.*

20(12):2775–82.

27(3):214–7.

and Polysulfone-Based Vitamin E-Bonded Dialysis Membranes 301

Galli, F.; Floridi, A. & Buoncristiani U. (2002). Oxidant stress in hemodialysis patients.

Galli, F. (2007). Protein damage and inflammation in uraemia and dialysis patients. *Nephrol* 

Huraib, S.; Tanimu, D.; Shaheen, F.; Hejaili, F.; Giles, C. & Pagayon, V. (2000). Effect of

Kirmizis, D.; Papagianni, A.; Belechri, AM. & Memmos, D. (2010). Effects of vitamin E-

Kojima, K.; Oda, K.; Homma, H.; Takahashi, K.; Kanda, Y.; Inokami, T. & Uchida, S. (2005).

Krane, V.; Krieter, DH.; Olschewski, M.; Marz, W.; Mann, JF.; Ritz, E. & Wanner, C. (2007).

Libetta, C.; Zucchi, M.; Gori, E.; Sepe, V.; Galli, F.; Meloni, F.; Milanesi, F. & Dal Canton, A.

Mandolfo, S.; Corradi, B.; Bucci, R.; Barbisoni, F.; Farina, M; Pilolli F. & Galli, F. (in press)

Matsumura, M.; Sasaki, H.; Sekizuka, K.; Sano, H.; Ogawa, K.; Shimizu, C.; Yoshida, H.;

Miyazaki, H.; Matsuoka, H.; Itabe, H.; Usui, M.; Ueda, S. & Okuda, S. (2000). Imaizumi T.

Morimoto, H.; Nakao, K.; Fukuoka, K.; Sarai, A.; Yano, A.; Kihara, T.; Fukuda, S.; Wada, J. &

Mydlik, M.; Derzsiova, K.; Racz, O.; Sipulova, A.; Lovasova, E.; Molcanyiova, A. &

Nakatani, T.; Takemoto, Y. & Tsuchida, AK. (2003). The effect of vitamin E-bonded dialyzer

Odetti, P.; Traverso, N.; Monacelli, F.; Menini, S.; Vazzana, J.; Tasso, B.; Pronzato, MA.;

parameters: three-month study. *Semin Nephrol.* 24(5):525–31.

maintenance hemodialysis. *Am J Kidney Dis*. 49(2):267–75.

vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin

coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis. *Nephrol Dial Transplant*. [Epub ahead of print]*.*  Kobayashi, S.; Moriya, H.; Aso, K. & Ohtake, T. (2003) Vitamin E-bonded hemodialyzer

improves atherosclerosis associated with a rheological improvement of circulating

Effect of vitamin E-bonded dialyzer on eosinophilia in haemodialysis patients.

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on

(2004). Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in

Evaluation of the impact of a new synthetic Vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheter: a

Kobayashi, S.; Koremoto, M.; Aritomi, M. & Ueki, K. (2010). Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane

Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-

Makino, H. (2005). Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in hemodialysis patients. *Nephrol Dial Transplant*.

Petrovicova, J. (2004). Vitamin E-coated dialyzer and antioxidant defense

membrane on red blood cell survival in hemodialyzed patients. *Artif Organs.* 

Robaudo, C. & Deferrari, G. (2006). Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions. *Free Radic Res*. 40(2):207–12. Omata, M.; Higuchi, C.; Demura, R.; Sanaka, T. & Nihei, H. (2000). Reduction of neutrophil activation by vitamin E modified dialyzer membranes. *Nephron*. 85(3):221–31.

Galli, F. & Azzi, A. (2010). Present trends in vitamin E research. *Biofactors* 36(1):33-42.

dosage: a comparative crossover study. *Am J Nephrol*. 20(5):364–8.

reported positive effects on ERI and anemia management, provide convincing and clinically relevant evidence. Early findings also suggest a better control of inflammatory and oxidative stress parameters. Anticoagulation and IDH are other potentially relevant aspects in the clinical application of VitabranE. These results suggest that VitabranE has superior performance than other synthetic membranes. Further and more comprehensive trials are needed for detailed verification of these clinical outcomes.

#### **5. References**


reported positive effects on ERI and anemia management, provide convincing and clinically relevant evidence. Early findings also suggest a better control of inflammatory and oxidative stress parameters. Anticoagulation and IDH are other potentially relevant aspects in the clinical application of VitabranE. These results suggest that VitabranE has superior performance than other synthetic membranes. Further and more comprehensive trials are

Andrulli, S.; Di Filippo, S.; Manzoni, C.; Stefanelli, L.; Floridi, A.; Galli, F. & Locatelli, F.

Aoun, B.; Janssen-Lozinska, Y. & Ulinski, T. (2010). Effect of vitamin E coated dialyzers on

Baragetti, I.; Furiani, S.; Vettoretti, S.; Raselli, S.; Maggi, FM.; Galli, F.; Catapano, AL. &

Boaz, M.; Smetana, S.; Weinstein, T.; Matas, Z.; Gafter, U.; Iaina, A.; Knecht, A.; Weissgarten,

Bufano, G.; Usberti, M.; Mandolfo, S.; Malberti, F.; Piroddi, M. & Galli, F. (2004). Von

Calò, LA; Naso, A; D'Angelo, A.; Pagnin, E.; Zanardo, M. & Puato, M. (2011). Rebeschini M,

Cruz, DN.; De Cal, M.; Garzotto, F.; Brendolan, A.; Nalesso, D.; Corradi, V. & Ronco, C.

Del Vecchio, L.; Locatelli, F. & Carini, M. (2011). What we know about oxidative stress in

Floridi, A.; Piroddi, M.; Pilolli, F.; Matsumoto, Y.; Aritomi, M. & Galli F. (2009). Analysis

randomised placebo-controlled trial. *Lancet.* 356(9237):1213-8. Bowry, SK. (2002). Dialysis membranes today. *Int J Artif Organs.* 25(5):447-60.

(2010). Effect of Synthetic Vitamin E-Bonded Membrane on Responsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Pilot Study.

anticoagulation requirement in hemodialyzed children. *Saudi J Kidney Dis Transpl*.

Buccianti, G. (2006). Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study. *Blood Purif.* 

Y.; Brunner, D.; Fainaru, M. & Green, MS. (2000). Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE):

Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialyzers. *Int J Artif Organs*. 27(3):214–21. Calò, LA.; Naso, A.; Pagnin, E.; Davis, PA.; Castoro, M.; Corradin, R.; Riegler, P.; Cascone,

C.; Huber, W. & Piccoli, A. (2004). Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis--a molecular biological

Landini S, Feriani M, Perego A, Malagoli A, Zagatti R, Calzavara P, Cascone C, Davis PA. Molecular biology-based assessment of vitamin E-coated dialyzer effects on oxidative stress, inflammation, and vascular remodeling. *Artif Organs.* 35(2):E33–9. Clermont, G.; Lecour, S.; Cabanne, JF.; Motte, G.; Guilland, JC.; Chevet, D. & Rochette, L.

(2001). Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients.

(2008). Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study. *Int J Artif Organs*. 31(6):545–52.

patients with chronic kidney disease on dialysis-clinical effects, potential treatment,

method and characterization of the antioxidant capacity of vitamin E-interactive

needed for detailed verification of these clinical outcomes.

*Nephron Clin Pract*. 115(1):c82–c89.

approach. *Clin Nephrol.* 62(5):355–61.

*Free Radic Biol Med.* 31(2):233–41.

and prevention. *Semin Dial.* 24(1):56–64.

polysulfone hemodialyzers. *Acta Biomater*. 5(8):2974–82. Galli, F. (2002). Vitamin E-modified dialyzers. *Contrib Nephrol.* 137:95–105.

**5. References** 

21(3):466–70.

24(4):369–76.


Panichi, V.; Rosati, A.; Paoletti, S.; Ferrandello, P.; Migliori, M.; Beati, S.; Bernabini, G.; Daini,

Pertosa, G.; Grandaliano, G.; Soccio, M.; Martino, C.; Gesualdo, L. & Schena, FP. (2002).

Piroddi, M.; Depunzio, I.; Calabrese, V.; Mancuso, C.; Aisa, CM.; Binaglia, L.; Minelli, A.;

Rousseau, Y.; Carreno, MP.; Poignet, JL.; Kazatchkine, MD. & Haeffner-Cavaillon, N. (1999).

Sasaki, M.; Hosoya, N. & Saruhashi, M. (2000). Vitamin E modified cellulose membrane.

Sasaki, M. (2006). Development of vitamin E-modified polysulfone membrane dialyzers. *J* 

Sosa, MA.; Balk, EM.; Lau, J.; Liangos, O.; Balakrishnan, VS.; Madias, NE.; Pereira, BJ. &

Tsuruoka, S.; Kawaguchi, A.; Nishiki, K.; Hayasaka, T.; Fukushima, C.; Sugimoto, K.; Saito,

Usberti, M.; Gerardi, G.; Bufano, G.; Tira, P.; Micheli, A.; Albertini, A.; Floridi, A.; Di

Westhuyzen, J.; Saltissi, D. & Stanbury, V. (2003). Oxidative stress and erythrocyte integrity

Yang, CC.; Hsu, SP.; Wu, MS.; Hsu, SM. & Chien, CT. (2006). Effects of vitamin C infusion

Yoshida, K.; Kitauchi, T.; Kimura, S.; Yoneda, T.; Uemura, H.; Ozono, S. & Hirao, Y. (2002).

Zaluska, WT.; Ksiazek, A. & Roliski, J. (2001). Effect of vitamin E modified cellulose

adhesion molecule expression during hemodialysis. *ASAIO J*. 47(6):619–22.

membrane influence on biocompatibility. *Artif Organs.* 26(1):54–7.

biomarkers of lipid peroxidation. *Nephrol Dial Transplant*. 21(10):2825–33. Tarng, DC.; Huang, TP.; Liu, TY.; Chen, HW.; Sung, YJ. & Wei, YH. (2000). Effect of vitamin

a Randomized Cross-Over Multicenter Trial. *Blood Purif*. 32(1):7–14.

blood mononuclear cells. *Kidney Int*. 62(2):602–10.

during hemodialysis. *Biomaterials.* 20(20):1959–67.

of hemodialysis patients. *Kidney Int.* 58(2):790–9.

patients. *Am J Kidney Dis*. 40(3):590–9.

membrane. *Ann Clin Lab Sci*. 33(1):3–10.

32(4):573–92.

*Artif Organs*. 24(10):779–89.

*Artif Organs*. 9(1):50–60.

*Dis*. 39(1):127–33.

*Int.* 69(4):706–14.

R.; Casani, A.; Angelini, D.; Parrini, M.; Rossi, A.; Petrone, I.; Barsotti, G.; Donadio, C.; Donati, G.; Grazi, G.; Manca Rizza, G.; Garosi, G.; Sansoni, E.; Braccagni, B.; Sidoti, A.; Boracelli, D.; Biagioli, M.; Moriconi, L.; Finato, V.; Mannarino, A.; Grimaldi, C.; Pansa, F.; Imperiali, P.; Mura, C.; Bianchi, S. & Bigazzi, R. (2011). A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of

Vitamin E-modified filters modulate Jun N-terminal kinase activation in peripheral

Butterfield, AD. & Galli, F. (2007). Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients. *Amino Acids.* 

Dissociation between complement activation, integrin expression, and neutropenia

Jaber, BL. (2006). A systematic review of the effect of the Excebrane dialyser on

E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA

T. & Fujimura, A. (2002). Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. *Am J Kidney* 

Lorenzo, D. & Galli, F. (2002). Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed

in end-stage renal failure patients hemodialysed using a vitamin E-modified

and vitamin E-coated membrane on hemodialysis-induced oxidative stress. *Kidney* 

Serum neopterin monitoring and vitamin E-modified, regenerated hemodialyzer

membrane on human lymphocyte, monocyte, and granulocyte CD11b/CD18
